Collaborating Authors


Iran plans 20 percent uranium enrichment 'as soon as possible'

FOX News

Center for Security Policy CEO Fred Fleitz provides insight on'America's News HQ.' DUBAI, United Arab Emirates (AP) -- Iran said Saturday it plans to enrich uranium up to 20% at its underground Fordo nuclear facility "as soon as possible," pushing its program a technical step away from weapons-grade levels as it increases pressure on the West over the tattered atomic deal. The move comes amid heightened tensions between Iran and the U.S. in the waning days of the administration of President Donald Trump, who unilaterally withdrew America from Tehran's nuclear deal in 2018. That set in motion an escalating series of incidents capped by a U.S. drone strike that killed a top Iranian general in Baghdad a year ago, an anniversary coming Sunday that has American officials now worried about possible retaliation by Iran. Iran's decision to begin enriching to 20% a decade ago nearly brought an Israeli strike targeting its nuclear facilities, tensions that only abated with the 2015 atomic deal. A resumption of 20% enrichment could see that brinksmanship return.

Face masks reduce our ability to recognise someone by 15 per cent

Daily Mail - Science & tech

Face masks do make it harder to identify people because it covers the nose and mouth, key features the human brain uses to put names to faces. A study from Israel revealed wearing a mask reduces a person's ability to recognise people by 15 per cent. However, people are able to still identify people they know best due to familiarity of their eyes and other parts of the face not covered by masks. Masks have become ubiquitous around the world in the wake of the coronavirus pandemic and as people try to avoid catching and spreading Covid-19. But they pose their own issues, researchers say, inhibiting social interactions and making it harder for people to talk to each other.

Gun that killed Iran's nuke scientist used 'artificial intelligence,' IRGC says


A satellite-controlled machine gun with "artificial intelligence" was used in last week's assassination of a top nuclear scientist in Iran, the deputy commander of the country's elite Islamic Revolutionary Guard Corps told local media Sunday. Mohsen Fakhrizadeh, long regarded by Israel and the US as the head of Iran's rogue nuclear weapons program, was driving on a highway outside Iran's capital Tehran with a security detail of 11 Guards on November 27, when the machine gun "zoomed in" on his face and fired 13 rounds, said Rear-admiral Ali Fadavi. The machine gun was mounted on a Nissan pickup and "focused only on martyr Fakhrizadeh's face in a way that his wife, despite being only 25 centimeters (10 inches) away, was not shot," the Mehr news agency quoted IRGC chief Fadavi as saying. Get The Times of Israel's Daily Edition by email and never miss our top stories Free Sign Up It was being "controlled online" via a satellite and used an "advanced camera and artificial intelligence" to make the target, he added. Fadavi said that Fakhrizadeh's head of security took four bullets "as he threw himself" on the scientist, and that there were "no terrorists at the scene."

How AI Helps Advance Immunotherapy And Precision Medicine


While immunotherapies have revolutionized cancer treatment, they are currently effective only for a small subset (from 20% to 30%) of patients. Tel-Aviv-based Nucleai is developing AI software for image analysis and modeling of pathology data to assist in the development of more effective drugs. The long-term goal of the 3-year-old startup is to be "a leader in precision medicine," says its co-founder and CEO, Avi Veidman. Nucleai's team has more than 50 years of cumulative AI experience gained in the Israeli Intelligence Corps--including satellite image analysis--plus the expertise of physicians and healthcare professionals, resulting in a multi-disciplinary approach to the challenge of ineffective predictive biomarkers. To find a better answer, "we combine different sources of information, just like what we did in intelligence," says Veidman. "The cancer does not care about your specialty," he observes.

Nuclear scientist killed in Iran by machine gun with 'artificial intelligence'


A satellite-controlled machine gun equipped with "artificial intelligence" was used to assassinate Iran's chief nuclear scientist, according to officials in the country. Mohsen Fakhrizadeh, who founded Iran's nuclear program in the 2000s, had a security detail of 11 guards while traveling with his wife on Nov. 27 in a car on a highway outside Tehran when an automatic machine gun outfitted with AI and an advanced camera zoomed in on his face and fired 13 times, an Islamic Revolutionary Guards Corps deputy commander told local media Sunday. "The machine gun was equipped with artificial intelligence to target martyr Fakhrizadeh," Rear Adm. Ali Fadavi said Sunday, according to the Mehr news agency. "The gun was focused only on martyr Fakhrizadeh, and his wife was not shot, despite being a few centimeters away." The head of Fakhrizadeh's security detail, meanwhile, was shot four times when he threw himself on the scientist, Fadavi said, adding that no attackers were at the scene.

Starfinder – Powerd by Roche & aMoon


Roche, a Swiss healthcare giant with global reach, teams up with one of the leading Israeli healthcare and life sciences VC firm, aMoon, on a collaborative investment program aimed at accelerating innovative diagnostic technologies from Israel's healthtech ecosystem. The collaboration, called "StarFinder Lab," will provide funding, mentoring, and strategic support to "9 Stars," newly-formed or existing ventures, elected through the program. The partnership focuses on identifying and cultivating disruptive AI-driven data as well as digital healthcare solutions from early-stage startups providing different technological solutions for the many different moving aspects of healthcare. "Healthtech and AI are transforming the healthcare industry as we know it, and we see great value in working with Israeli healthcare innovators as they build their companies," said Michele Pedrocchi, Head of Global Strategy and Business Development at Roche Diagnostics. The joint venture will create an innovative atmosphere, where selected startups will receive access to global expertise from the Roche and aMoon.

Iran's supreme leader vows revenge over slain scientist

Boston Herald

TEHRAN, Iran (AP) -- Iran's supreme leader on Saturday demanded the "definitive punishment" of those behind the killing of a scientist who led Tehran's disbanded military nuclear program, as the Islamic Republic blamed Israel for a slaying that has raised fears of reignited tensions across the Middle East. After years of being in the shadows, the image of Mohsen Fakhrizadeh suddenly was to be seen everywhere in Iranian media, as his widow spoke on state television and officials publicly demanded revenge on Israel for the scientist's slaying. Israel, long suspected of killing Iranian scientists a decade ago amid earlier tensions over Tehran's nuclear program, has yet to comment on Fakhrizadeh's killing Friday. However, the attack bore the hallmarks of a carefully planned, military-style ambush, the likes of which Israel has been accused of conducting before. The attack has renewed fears of Iran striking back against the U.S., Israel's closest ally in the region, as it did earlier this year when a U.S. drone strike killed a top Iranian general.

Iran scientist linked to military nuclear program killed

Boston Herald

An Iranian scientist named by the West as the leader of the Islamic Republic's disbanded military nuclear program was killed Friday in an ambush on the outskirts of Tehran, authorities said. Iran's foreign minister alleged the killing of Mohsen Fakhrizadeh bore "serious indications" of an Israeli role, but did not elaborate. Israel, long suspected of killing several Iranian nuclear scientists a decade ago, declined to immediately comment. Israeli Prime Minister Benjamin Netanyahu once told the public to "remember that name" when talking about Fakhrizadeh. The killing risks further raising tensions across the Mideast, nearly a year after Iran and the U.S. stood on the brink of war when an American drone strike killed a top Iranian general in Baghdad.

Robot dog and Sparrow drone to team up for missions


Industrial inspection continues to be a driver of growth in the automation sector. Case in point, a $45M Series B for Percepto, which makes a drone-in-a-box system for inspection and monitoring. The fundraise comes as Percepto expands its footprint in autonomous inspection via its Percepto's Autonomous Inspection & Monitoring (AIM) platform, which harnesses third-party remote robotics. Along with Percepto's Sparrow drone, the first robot to be deployed using AIM will be Boston Dynamics' Spot robotic quadruped. Based in Israel, Percepto has led the way in the fast-moving market for robotic inspection solutions.

SentinelOne, an AI-based endpoint security firm, confirms $267M raise on a $3.1B valuation – TechCrunch


This year, more than ever before because of the COVID-19 pandemic, huge droves of workers and consumers have been turning to the internet to communicate, get things done and entertain themselves. That has created a huge bonanza for cybercriminals, but also companies that are building tools to combat them. In the latest development, an Israel-hatched, Mountain View-based enterprise startup called SentinelOne -- which has built a machine learning-based solution that it sells under the brand Singularity that works across the entire edge of the network to monitor and secure laptops, phones, containerised applications and the many other devices and services connected to a network -- has closed $267 million in funding to continue expanding its business to meet demand, which has seen business boom this year. Its valuation is now over $3 billion. Given the large sums the company has now raised -- $430 million to date -- the funding will likely be used for acquisitions (cyber is a very crowded market and will likely see some strong consolidation in the coming years), as well as more in-house development and sales and marketing.